# Peter J. Blankestijn

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-j-blankestijn/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,711 |
| Field | Dialysis and Renal Disease Management |
| h-index | 70 |
| i10-index | 269 |
| Last Known Institution | Utrecht University |
| OpenAlex ID | https://openalex.org/A5054652495 |
| ORCID iD | 0000-0003-4289-632X |
| Works | 445 |

## Researcher papers

Showing 12 of 18.

- [Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial](https://scholariq.org/papers/endovascular-ultrasound-renal-denervation-to-treat-hypertension-radiance-htn/)
- [Effect of Online Hemodiafiltration on All-Cause Mortality and Cardiovascular Outcomes](https://scholariq.org/papers/effect-of-online-hemodiafiltration-on-all-cause-mortality-and-cardiovascular/)
- [Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk](https://scholariq.org/papers/carotid-intima-media-thickness-progression-as-surrogate-marker-for/)
- [Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis](https://scholariq.org/papers/associations-of-kidney-disease-measures-with-mortality-and-end-stage-renal-2/)
- [Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/dialysis-initiation-modality-choice-access-and-prescription-conclusions-from-a/)
- [Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal Failure](https://scholariq.org/papers/reduction-of-sympathetic-hyperactivity-by-enalapril-in-patients-with-chronic/)
- [Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials](https://scholariq.org/papers/change-in-albuminuria-as-a-surrogate-endpoint-for-progression-of-kidney-disease/)
- [Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation](https://scholariq.org/papers/sympathetic-activation-markedly-reduces-endothelium-dependent-flow-mediated/)
- [Hemodialysis Arteriovenous Fistula Patency Revisited](https://scholariq.org/papers/hemodialysis-arteriovenous-fistula-patency-revisited/)
- [Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes](https://scholariq.org/papers/estimated-glomerular-filtration-rate-albuminuria-and-adverse-outcomes/)
- [Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis](https://scholariq.org/papers/serum-potassium-and-adverse-outcomes-across-the-range-of-kidney-function-a-ckd/)
- [Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies](https://scholariq.org/papers/change-in-albuminuria-and-subsequent-risk-of-end-stage-kidney-disease-an/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Central Venous Catheters and Hemodialysis](https://scholariq.org/topics/central-venous-catheters-and-hemodialysis/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)

## Researcher university

- [Utrecht University](https://scholariq.org/institutions/utrecht-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.